Sponsor or institution

Clinical trials and research at Nanjing RegeneCore Biotech Co., Ltd.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Nanjing RegeneCore Biotech Co., Ltd. that are recruiting, in China. By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
RC1416 shots for moderate to severe asthma Phase 2 Anqing, Anhui and 43 other locations Recruiting Feb 11, 2026
RC1416 injection for moderate to severe COPD Phase 2 Hefei, Anhui and 45 other locations Recruiting Feb 11, 2026
First-in-human testing of RJK-RT2831 to find a safe dose and understand how the drug behaves in the body. Phase 1 Hefei, Anhui and 15 other locations Recruiting Jan 3, 2025

All recruiting trials (3)

Quick answers

How many clinical trials run by Nanjing RegeneCore Biotech Co., Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.